McKesson Corporation, a heavyweight in the Healthcare sector, specifically within the Medical Distribution industry, currently boasts a commanding market capitalization of $92.45 billion. Despite a mild 24-hour uptick of 1.49%, the asset has faced significant short-term headwinds, losing 9.61% over the past seven days to trade at $754.76.

From a purely technical perspective, the AlgoTrend scoring model assigns McKesson a Strong Sell rating, driven by a total score of -4 out of an available range of -6 to +6. The predominant factor is the negative price trend: at $754.76, the stock is trading well below its 200-day Simple Moving Average of $813.15, generating a -2 penalty. This downward momentum is robust, as indicated by an ADX of 38.58 combined with a dominant DMI- (46.41) overshadowing the DMI+ (7.79). Furthermore, the MACD histogram is in bearish territory (-6.98), and volume analysis points to distribution, with the On-Balance Volume (OBV) trailing its 5-day SMA. The only technically positive signal comes from the RSI, which sits at a deeply oversold 22.24, providing a solitary +1 point to the aggregate score.

In contrast to the highly bearish technical landscape, McKesson's fundamental and earnings profile paints a rather complex picture. The company maintains a reasonable P/E ratio of 19.64 and reports a massive, albeit highly unusual, dividend yield of 43.0%. Looking at its latest financial performance, McKesson delivered an impressive EPS of $4.27, representing a staggering 404.0% upside surprise, though the date for its next quarterly report remains unavailable. Ultimately, while the underlying earnings and fundamentals suggest strong operational health, traders should exercise caution. The technical "Strong Sell" rating implies that bearish market sentiment is currently overriding the robust fundamentals, though the oversold RSI hints at a potential near-term relief rally.